Supercharging Small Molecules & Degraders
to Target the Kinome
Welcome to the 3rd Kinase Targeted Drug Discovery Summit
Propel Kinase Biology Understanding to Increase Selectivity, Overcome Resistance & Find the Optimal Combination Partner to Develop Best & First-in-Class Kinase Targeted Drugs
The kinase drug discovery field is at a pivotal moment, with recent breakthroughs from industry leaders such as Biogen, A-Alpha Bio, and Proxygen paving the way for exciting new approaches in targeting kinases, particularly in targeted protein degradation.
However, with ongoing challenges including selectivity and resistance in small molecule inhibitors, these hurdles limit the therapeutic applications and call for in-depth discussions focused on innovative future strategies for kinase targeted drugs.
Join us at the 3rd Kinase Targeted Drug Discovery Summit; the premier, target-specific conference designed to provide you with ground-breaking insights to revolutionize your kinase biology.
Discover cutting-edge developments in small molecule therapeutics, including PROTACs, molecular glues, and allosteric inhibitors. Don’t miss your opportunity to enhance drug selectivity, tackle resistance head-on, and identify optimal combination partners. Lead the charge in creating first-class kinase-targeted drugs that can ultimately combat disease indications and transform patient outcomes!
FREE TO ATTEND FOR DRUG DEVELOPERS & RESEARCHERS*
*Free access is only granted once approval of eligibility is confirmed - please visit the Registration page for terms and conditions
2025 World-Class Speaker Faculty Includes:
Last Year Attending Companies Included:
What Your Peers Have to Say:
"The quality of the presentations was very high – I got the opportunity to meet potential new collaborators"
"It was a great blend of industry and academic researchers, alongside vendors truly enabling new technologies"
“The size of the meeting was just right to interact and network with everyone in the kinase community”
2025 Partners:
